Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient

Overview

While delivery of an FMT-treatment to the cecum is visualized in a lower GI-endoscopy, it is uncertain whether delivery by enema distributes the FMT to the proximal segments of the colon. Positioning of the patient during the enema procedure may improve distribution to the proximal colon. Differences in distribution may explain the wide effect range and inferiority when enema is compared to delivery by lower GI endoscopy. Thus, in this study we will compare the distribution of FMT from delivery by lower GI endoscopy versus enema with and without positioning of the patient. We will use contrast fluid as a surrogate liquid for FMT to project the distribution on colon X-ray pictures. To our knowledge this is not done in any previous study.

Full Title of Study: “Distribution of FMT After Delivery by · Lower GI Endoscopy vs· Enema With and Without Positioning of the Patient”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 18, 2022

Interventions

  • Other: Delivery of contrast fluid by lower GI endoscopy
    • Each participant will receive one delivery of 440 ml contrast fluid by lower GI endoscopy to the cecum of the colon. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. An colon X-ray is obtained within 10 minutes after the contrast fluid is delivered. The participants is in a supine position fram delivery and until the colon x-ray is obtained.
  • Other: Delivery of contrast fluid by enema with and without positioning
    • Each participant will receive one delivery of 440 ml contrast fluid by enema. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. The enema procedure includes: The participant lies on his/her left side in neutral position when the enema is delivered X-ray of the colon is obtained with the participant lying on his/her back. The participant is positioned back to his/her left sided position and tilted in a Trendelenburg position. The position is held for two minutes The participant is turned to an abdominal position while the bed remains tilted in Trendelenburg position. Participant turne to the right side. When positioned the bed is tilted the opposite way (anti-Trendelenburg.) The position is held for two minutes. A second colon X-ray is obtained after the participants has rested for ten minutes in a supine neutral position

Arms, Groups and Cohorts

  • Experimental: Contrast fluid by lower GI endoscopy and enema with and without positioning
    • There is a washout period of at least four weeks between the two interventions (delivery by lower GI endoscopy and enema)

Clinical Trial Outcome Measures

Primary Measures

  • Proportion of cecum projection after CF delivery by lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.
    • Time Frame: 10 minutes after contrast fluid delivery
    • Two radiologist determine the projection each colon X-ray picture by identifying segments where the gut mucosa is coated with contrast fluid and/or segments with contrast fluid in the lumen. The radiologist is blinded to which delivery method is used.

Secondary Measures

  • Proportion of transverse colon projection after CF delivery by the lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.
    • Time Frame: 10-20 minutes after contrast fluid delivery
    • Two radiologist determine the projection each colon X-ray picture by identifying segments where the gut mucosa is coated with contrast fluid and/or segments with contrast fluid in the lumen. The radiologist is blinded to which delivery method is used.

Participating in This Clinical Trial

Inclusion Criteria

  • Scheduled for colonoscopy at the medical department at UNN Harstad – Able to complete the positioning procedure during the enema Exclusion Criteria:

  • Confirmed malignancy – Inflammatory bowel disease – Referral highly suspicious of cancer, inflammatory bowel disease or obstructive GI disease – Contraindications for rectal catheter insertion (including known damage to pelvic floor, sphincter or the pudendal nerve) – Use of anticoagulants. Use of acetylsalicylic acid is allowed – Symptomatic cardiovascular or lung disease – Kidney failure – Known allergic reaction to any component in Liquid Polibar Plus – Pregnant, lactating or planning pregnancy – Asthma

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital of North Norway
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Peter H Johnsen, MD PhD, Principal Investigator, University Hospital of North Norway

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.